The DOI matches its Crossref record; 9 of the 9 references it cites were found in a registry or an index.
Persistent Pulmonary Hypertension of the Newborn in the Era Before Nitric Oxide: Practice Variation and Outcomes
Abstract
Objectives.: In the era before widespread use of inhaled nitric oxide, to determine the prevalence of persistent pulmonary hypertension (PPHN) in a multicenter cohort, demographic descriptors of the population, treatments used, the outcomes of those treatments, and variation in practice among centers. Study Design.: A total of 385 neonates who received ≥50% inspired oxygen and/or mechanical ventilation and had documented evidence of PPHN (2D echocardiogram or preductal or postductal oxygen difference) were tracked from admission at 12 Level III neonatal intensive care units. Demographics, treatments, and outcomes were documented. Results.: The prevalence of PPHN was 1.9 per 1000 live births (based on 71 558 inborns) with a wide variation observed among centers (.43–6.82 per 1000 live births). Neonates with PPHN were admitted to the Level III neonatal intensive care units at a mean of 12 hours of age (standard deviation: 19 hours). Wide variations in the use of all treatments studied were found at the centers. Hyperventilation was used in 65% overall but centers ranged from 33% to 92%, and continuous infusion of alkali was used in 75% overall, with a range of 27% to 93% of neonates. Other frequently used treatments included sedation (94%; range: 77%–100%), paralysis (73%; range: 33%–98%), and inotrope administration (84%; range: 46%–100%). Vasodilator drugs, primarily tolazoline, were used in 39% (range: 13%–81%) of neonates. Despite the wide variation in practice, there was no significant difference in mortality among centers. Mortality was 11% (range: 4%–33%). No specific therapy was clearly associated with a reduction in mortality. To determine whether the therapies were equivalent, neonates treated with hyperventilation were compared with those treated with alkali infusion. Hyperventilation reduced the risk of extracorporeal membrane oxygenation without increasing the use of oxygen at 28 days of age. In contrast, the use of alkali infusion was associated with increased use of extracorporeal membrane oxygenation (odds ratio: 5.03, compared with those treated with hyperventilation) and an increased use of oxygen at 28 days of age. Conclusions.: Hyperventilation and alkali infusion are not equivalent in their outcomes in neonates with PPHN. Randomized trials are needed to evaluate the role of these common therapies.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The Effectiveness of Right Heart Catheterization in the Initial Care of Critically III Patients
Connors, A. F. (1996) · JAMA: The Journal of the American Medical Association · doi:10.1001/jama.1996.03540110043030 · Cited by 2,210
Inhaled Nitric Oxide in Full-Term and Nearly Full-Term Infants with Hypoxic Respiratory Failure
(1997) · New England Journal of Medicine · doi:10.1056/nejm199702273360901 · Cited by 865
UK collaborative randomised trial of neonatal extracorporeal membrane oxygenation
(1996) · The Lancet · doi:10.1016/s0140-6736(96)04100-1 · Cited by 734
The Appropriateness of Carotid Endarterectomy
Winslow, C. M., Solomon, D. H., Chassin, M. R., Kosecoff, J., Merrick, N. J., & Brook, R. H. (1988) · New England Journal of Medicine · doi:10.1056/nejm198803243181201 · Cited by 488
The CASE for USING INDUSTRIAL QUALITY MANAGEMENT SCIENCE in HEALTH CARE ORGANIZATIONS
Laffel, G., & Blumenthal, D. (1993) · The Textbook of Total Quality in Healthcare · doi:10.4324/9781498702881-02 · Cited by 399
The Case for Using Industrial Quality Management Science in Health Care Organizations
Laffel, G. (1989) · JAMA: The Journal of the American Medical Association · doi:10.1001/jama.1989.03430200113036 · Cited by 303
The Appropriateness of Performing Coronary Artery Bypass Surgery
Winslow, C. M. (1988) · JAMA: The Journal of the American Medical Association · doi:10.1001/jama.1988.03410040077031 · Cited by 214
Wennberg, J. E. (1987) · JAMA · doi:10.1001/jama.1987.03390070053022 · Cited by 203
Horbar, J. D., Badger, G. J., Lewit, E. M., Rogowski, J., Shiono, P. H., & for the Vermont Oxford Network (1997) · Pediatrics · doi:10.1542/peds.99.2.149 · Cited by 179
Cited by
Abman, S. H., Hansmann, G., Archer, S. L., Ivy, D. D., Adatia, I., Chung, W. K., Hanna, B. D., Rosenzweig, E. B., Raj, J. U., Cornfield, D., et al. (2015) · Circulation · doi:10.1161/cir.0000000000000329 · Cited by 1,164
Selective Serotonin-Reuptake Inhibitors and Risk of Persistent Pulmonary Hypertension of the Newborn
Chambers, C. D., Hernandez-Diaz, S., Van Marter, L. J., Werler, M. M., Louik, C., Jones, K. L., & Mitchell, A. A. (2006) · New England Journal of Medicine · doi:10.1056/nejmoa052744 · Cited by 880
Rosenzweig, E. B., Abman, S. H., Adatia, I., Beghetti, M., Bonnet, D., Haworth, S., Ivy, D. D., & Berger, R. M. F. (2019) · European Respiratory Journal · doi:10.1183/13993003.01916-2018 · Cited by 628
Pediatric Pulmonary Hypertension
Ivy, D. D., Abman, S. H., Barst, R. J., Berger, R. M. F., Bonnet, D., Fleming, T. R., Haworth, S. G., Raj, J. U., Rosenzweig, E. B., Schulze Neick, I., et al. (2013) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2013.10.028 · Cited by 536
Physiology of Transition from Intrauterine to Extrauterine Life
Hillman, N. H., Kallapur, S. G., & Jobe, A. H. (2012) · Clinics in Perinatology · doi:10.1016/j.clp.2012.09.009 · Cited by 456
Metadata
- Authors
- Walsh-Sukys, M. C., Tyson, J. E., Wright, L. L., Bauer, C. R., Korones, S. B., Stevenson, D. K., Verter, J., Stoll, B. J., Lemons, J. A., Papile, L.-A., Shankaran, S., Donovan, E. F., Oh, W., Ehrenkranz, R. A., & Fanaroff, A. A.
- Venue
- Pediatrics
- Publisher
- American Academy of Pediatrics (AAP)
- Published
- 2000-01-01
- Volume
- 105
- Issue
- 1
- Pages
- 14-20
- ISSN
- 0031-4005 (ISSN-L)
- 1098-4275
- OpenAlex
- W2080793206
- Cited by
- 581
- References
- 9
- FWCI
- 12.30
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Persistent Pulmonary Hypertension of the Newborn in the Era Before Nitric Oxide: Practice Variation and Outcomes. https://app.cochat.ai/papers/10.1542/peds.105.1.14
- The paper
- Walsh-Sukys, M. C., Tyson, J. E., Wright, L. L., Bauer, C. R., Korones, S. B., Stevenson, D. K., Verter, J., Stoll, B. J., Lemons, J. A., Papile, L.-A., Shankaran, S., Donovan, E. F., Oh, W., Ehrenkranz, R. A., & Fanaroff, A. A. (2000). Persistent Pulmonary Hypertension of the Newborn in the Era Before Nitric Oxide: Practice Variation and Outcomes. Pediatrics. https://doi.org/10.1542/peds.105.1.14
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.